The FDA says Moderna’s vaccine is “highly effective” and could be approved this week

by

Washington – At a time when hundreds of people in the United States and Puerto Rico are vaccinated against COVID-19, regulators of the Federal Food and Drug Administration (FDA) are issuing a positive review of the Moderna vaccine, which promotes a second drug to achieve immunization against the SARS-CoV-2 virus.

The agency posted on its website the initial review confirming the effectiveness and safety of the vaccine developed by Moderna and the National Institutes of Health, bringing the injection to the pinnacle of US authorization.

“It’s highly effective,” the FDA said. In addition, the documents state that Moderna’s drug is 94% effective in preventing the disease and will not cause serious safety problems during studies.

A panel of outside experts will offer their recommendation on Thursday, with a final FDA decision expected as soon as next Friday.

The news comes when U.S. hospitals began increasing vaccines with the injection developed by Pfizer and BioNTech, which the FDA approved last week.

  • Ashford Hospital epidemiologist Hilda Alemán removes part of the vaccine against Pfizer's COVID-19 and BioNTech from the vial.

    Ashford Hospital epidemiologist Hilda Alemán removes part of the vaccine against Pfizer’s COVID-19 and BioNTech from the vial.

  • Respiratory therapist Yahaira Alicea was the first person vaccinated in Puerto Rico against COVID-19.

    Respiratory therapist Yahaira Alicea was the first person vaccinated in Puerto Rico against COVID-19.

  • Occupational health disease, Melisa Valentin, receives the COVID-19 vaccine at Ashford Hospital.

    Occupational health disease, Melisa Valentin, receives the COVID-19 vaccine at Ashford Hospital.

  • COVID-19 vaccine bottle developed by Pfizer and BioNTech.

    COVID-19 vaccine bottle developed by Pfizer and BioNTech.

  • Epidemiologist Hilda Alemán measures the correct dose of the COVID-19 vaccine at Ashford Hospital.

    Epidemiologist Hilda Alemán measures the correct dose of the COVID-19 vaccine at Ashford Hospital.

  • Pfizer reported that the vaccine it developed in conjunction with BioNTech is 95% effective.

    Pfizer reported that the vaccine it developed in conjunction with BioNTech is 95% effective.

  • Ashford Hospital room where the first vaccines against COVID-19 were administered.

    Ashford Hospital room where the first vaccines against COVID-19 were administered.

  • Urologist Roberto Carlo was another of the first people vaccinated against COVID-19 in Puerto Rico.

    Urologist Roberto Carlo was another of the first people vaccinated against COVID-19 in Puerto Rico.

  • Occupational health disease, Melisa Valentin, receives the COVID-19 vaccine at Ashford Hospital.

    Occupational health disease, Melisa Valentin, receives the COVID-19 vaccine at Ashford Hospital.

  • Pfizer and BioNTech’s COVID-19 vaccine works in double doses. Approximately three weeks after the first vaccination a second dose should be applied to the patient to complete the antiquity generation process.

    Pfizer and BioNTech’s COVID-19 vaccine works in double doses. Approximately three weeks after the first vaccination a second dose should be applied to the patient to complete the antiquity generation process.

  • Dr. Manuel Velilla, a gynecologist over the age of 75, was chosen to be vaccinated because of his risk of age before COVID-19.

    Dr. Manuel Velilla, a gynecologist over the age of 75, was chosen to be vaccinated because of his risk of age before COVID-19.

Packed in dry ice to keep in deep-frozen temperatures, shipments of Pfizer’s COVID-19 vaccine will reach an additional 400 hospitals and other distribution sites, a day after the nation’s death toll exceeded 300,000.

The first 3 million vaccines are being strictly rationed to front-line health workers as they care for elderly patients, with hundreds of millions more vaccines needed in the coming months to protect most Americans.

A second vaccine may not arrive soon enough as the country’s death recovery diary continues to surpass 2,400 amid more than 210,000 new cases daily, based on weekly averages of data collected by Johns Hopkins University.

Early vaccine deliveries have provided a measure of encouragement to doctors, nurses and hospital staff across the country.

.Source

Leave a Comment